Journal
CURRENT OBSTETRICS AND GYNECOLOGY REPORTS
Volume 2, Issue 2, Pages 76-85Publisher
SPRINGER
DOI: 10.1007/s13669-013-0040-0
Keywords
HPV; Cervical Cancer; Screening; Cervical Precancer; Detection of HPV; Prevention; Screening Programs
Categories
Ask authors/readers for more resources
Current cervical cancer screening programs are changing due to the development of tests that detect the presence of human papillomavirus (HPV), the cause of cervical cancer. These tests are more sensitive than cytology-based methods for detecting cervical precancer and a negative test offers long-termassurance that cervical cancer will not develop and therefore longer screening intervals can be achieved. In screening programs, HPV-based tests have been approved to triage women with equivocal cytology results and as a primary testing method in conjunction with cytology. HPV-based tests also have a role in determining risk of recurrence after treatment for cervical precancer as well as in surveillance for vaccine-related changes in HPV genotype prevalence.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available